Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole vs Tacrolimus for Atopic Dermatitis
NCT07437534Phase 4Not yet recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Mar 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AN2728 ointment vehicle, Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Hayatabad Medical Complex. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
AN2728 ointment vehicleTacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07437534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07437534.